1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis
    Meeting Abstract

    Sullivan, M.; Chui, M. H.; Roche, K. L.; Sonoda, Y.; Grisham, R.; Momeni-Boroujeni, A.; Weigelt, B.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Use of frontline maintenance treatment following cytoreductive surgery in advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering team ovary study
    Meeting Abstract

    Finch, L.; Finlan, M.; Broach, V.; Chi, D.; Roche, K. L.; Gardner, G.; Al-Niaimi, A.; O'Cearbhaill, R.; Grisham, R.; Abu-Rustum, N.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Long survival in patients with adnexal high-grade serous carcinoma who underwent suboptimal cytoreductive surgery: A whole-genome analysis
    Meeting Abstract

    Sullivan, M.; Brown, D.; Paula, A. D.; Boerner, T.; O'Cearbhaill, R.; Tew, W.; Grisham, R.; Sonoda, Y.; Leitao, M.; Broach, V.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Impact of hyperthermic intraperitoneal chemotherapy at time of secondary cytoreductive surgery on immediate platinum resistance: A Memorial Sloan Kettering team ovary study
    Meeting Abstract

    Praiss, A.; Donohoe, F.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Broach, V.; Al-Niaimi, A.; Gardner, G.; Roche, K. L.; O'Cearbhaill, R.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Randomized, phase II/III study of pegylated liposomal doxorubicin, bevacizumab, and atezolizumab in platinum-resistant ovarian cancer (NRG-GY009): Clinical outcomes by PD-L1 and T cell infiltration status
    Meeting Abstract

    O'Cearbhaill, R.; Zamarin, D.; Sill, M.; Duong, H.; Waggoner, S.; Grisham, R.; Backes, F.; Mannel, R.; Tanyi, J.; Powell, M.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy of budesonide monotherapy for low grade GI GVHD after post transplant cyclophosphamide
    Meeting Abstract

    Cook, M.; Vadakkel, G.; Chinapen, S.; Perales, M. A.; Tamari, R.; Papadopoulos, E. B.; Ponce, D. M.; Shaffer, B. C.; Lin, A.
    Blood (2024)

    Fulltext@MSK | Save
  • GVHD therapy with ruxolitinib is frequently associated with cytopenias, but significant decline in hemoglobin level was only observed in non-responders at day 28
    Meeting Abstract

    Gergoudis, S.; Devlin, S. M.; Susman, P.; Singh, A.; Chinapen, S.; Perales, M. A.; Ponce, D. M.
    Blood (2024)

    Fulltext@MSK | Save
  • Proliferation of a novel CD3(neg) hyperactivated T-cell population characterizes adult hemophagocytic lymphohistiocytosis and associates with disease activity
    Meeting Abstract

    Rocco, J. M.; Laidlaw, E.; Yates, B.; Schroeder, B.; Limerick, E.; Johnson, W. T.; Oved, J. H.; Galindo, F.; Ewing, W.; Fitzhugh, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Teo, M. Y.; Bajorin, D.; Kotecha, R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save